Citation Impact
Citing Papers
Keeping G Proteins at Bay: A Complex Between G Protein-Coupled Receptor Kinase 2 and Gßγ
2003 StandoutScienceNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
2005 StandoutNobel
Age-related changes of myocardial ATP supply and demand mechanisms
2013
Protein Kinase A and G Protein-coupled Receptor Kinase Phosphorylation Mediates β-1 Adrenergic Receptor Endocytosis through Different Pathways
2003 StandoutNobel
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
β-Arrestin Scaffolding of Phosphatidylinositol 4-Phosphate 5-Kinase Iα Promotes Agonist-stimulated Sequestration of the β2-Adrenergic Receptor
2008 StandoutNobel
The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review
2007
Universal Definition of Myocardial Infarction
2007 Standout
Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes
2016
Prospects for Cardiovascular Research
2001 StandoutNobel
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
The prognostic value of body mass index and standard exercise testing in male Veterans with congestive heart failure
2002
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
Review of Trials in Chronic Heart Failure Showing Broad-Spectrum Anti-Inflammatory Approaches
2005
Prognosis determination in heart failure
2001
Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension
2014
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
2006 Standout
Insights into the pathogenesis of chronic heart failure: immune activation and cachexia
1999
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease
2014
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Endothelial Dysfunction, Arterial Stiffness, and Heart Failure
2012
Nonalcoholic Fatty Liver Disease Is Associated with Aortic Valve Sclerosis in Patients with Type 2 Diabetes Mellitus
2014
Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2
2007 StandoutNobel
Non-alcoholic fatty liver disease
2021 Standout
Trends in Heart Failure Incidence and Survival in a Community-Based Population
2004 Standout
Myocarditis
2011 Standout
Left Ventricular Dysfunction in Obese Children and Adolescents With Nonalcoholic Fatty Liver Disease
2013
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
2013
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes
2014
Secondary prevention with folic acid: effects on clinical outcomes
2003
Obesity and the Risk of Heart Failure
2002 Standout
The role of tumor necrosis factor in the pathophysiology of heart failure
2000
Listing Criteria for Heart Transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006
2006
Manganese‐enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations
2004
Myocarditis
2000 Standout
Non-Alcoholic Fatty Liver Disease Is Associated with an Increased Incidence of Atrial Fibrillation in Patients with Type 2 Diabetes
2013
High‐dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature
2002
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
2007 StandoutNobel
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Expression of SERCA isoform with faster Ca2+ transport properties improves postischemic cardiac function and Ca2+ handling and decreases myocardial infarction
2007
Clinical Perspectives
1998
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Predicting Mortality Among Patients Hospitalized for Heart Failure
2003 Standout
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
2016
NAFLD: A multisystem disease
2015 Standout
Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
2016
Biomarkers in Heart Failure
2008 Standout
Human viral cardiomyopathy
2003
Myocarditis
2009 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
C‐reactive protein as a predictor of improvement and readmission in heart failure
2002
Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy
2001
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
2017
β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes
2006 StandoutNobel
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
2006 Standout
Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α
1997
Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with Type 2 diabetes
2013
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis
2004 StandoutNobel
Myocardial viability assessment by contrast-enhanced magnetic resonance imaging
2003
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction
2003
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Level of β-Adrenergic Receptor Kinase 1 Inhibition Determines Degree of Cardiac Dysfunction After Chronic Pressure Overload–Induced Heart Failure
2005 StandoutNobel
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Works of Guy A. MacGowan being referenced
Pressure-calcium relationships in perfused mouse hearts
2006
Impact of β-blocker therapy on functional capacity criteria for heart transplant listing
2003
Calcium Measurements in Perfused Mouse Heart: Quantitating Fluorescence and Absorbance of Rhod-2 by Application of Photon Migration Theory
2001
Intravenous immune globulin in the therapy of peripartum cardiomyopathy
1999
Exercise-Related Ventilatory Abnormalities and Survival in Congestive Heart Failure
1997
Circulating Interleukin-6 in Severe Heart Failure
1997
Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease
2012
Manganese‐enhanced MRI of mouse heart during changes in inotropy†
2001
Cardiac structure and function are altered in type 2 diabetes and Non-alcoholic fatty liver disease and associate with glycemic control
2015
Left ventricular torsion, energetics, and diastolic function in normal human aging
2011
Effect of the Asp 298 Variant of Endothelial Nitric Oxide Synthase on Survival for Patients With Congestive Heart Failure
2003
Pharmacogenetic Interactions Between β-Blocker Therapy and the Angiotensin-Converting Enzyme Deletion Polymorphism in Patients With Congestive Heart Failure
2001
Noninvasive Measurement of Shortening in the Fiber and Cross-Fiber Directions in the Normal Human Left Ventricle and in Idiopathic Dilated Cardiomyopathy
1997